Advertisement

Analysis of Conventional and Unconventional Trafficking of CFTR and Other Membrane Proteins

  • Heon Yung Gee
  • Joo Young Kim
  • Min Goo LeeEmail author
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1270)

Abstract

The cystic fibrosis transmembrane conductance regulator (CFTR) is a polytopic transmembrane protein that functions as a cAMP-activated anion channel at the apical membrane of epithelial cells. Mutations in CFTR cause cystic fibrosis and are also associated with monosymptomatic diseases in the lung, pancreas, intestines, and vas deferens. Many disease-causing CFTR mutations, including the deletion of a single phenylalanine residue at position 508 (ΔF508-CFTR), result in protein misfolding and trafficking defects. Therefore, intracellular trafficking of wild-type and mutant CFTR has been studied extensively, and results from these studies significantly contribute to our general understanding of mechanisms involved in the cell-surface trafficking of membrane proteins. CFTR is a glycoprotein that undergoes complex N-glycosylation as it passes through Golgi-mediated conventional exocytosis. Interestingly, results from recent studies revealed that CFTR and other membrane proteins can reach the plasma membrane via an unconventional alternative route that bypasses Golgi in specific cellular conditions. Here, we describe methods that have been used to investigate the conventional and unconventional surface trafficking of CFTR. With appropriate modifications, the protocols described in this chapter can also be applied to studies investigating the intracellular trafficking of other plasma membrane proteins.

Key words

Membrane protein Unconventional trafficking Cystic fibrosis transmembrane conductance regulator (CFTR) Surface biotinylation Immunofluorescence staining 

Notes

Acknowledgments

We thank Shin Hye Noh and Joonhee Park for editorial assistance. This work was supported by grants 2013R1A3A2042197 and 2007-0056092 from the National Research Foundation, the Ministry of Science, ICT & Future Planning, and grant HI14C0070 from the Korean Health Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. The authors have no conflict of interest to disclose.

References

  1. 1.
    Lee MG, Ohana E, Park HW, Yang D, Muallem S (2012) Molecular mechanism of pancreatic and salivary gland fluid and HCO3 secretion. Physiol Rev 92:39–74CrossRefPubMedCentralPubMedGoogle Scholar
  2. 2.
    Park HW, Lee MG (2012) Transepithelial bicarbonate secretion: lessons from the pancreas. Cold Spring Harb Perspect Med 2:a009571Google Scholar
  3. 3.
    Gee HY, Noh SH, Tang BL, Kim KH, Lee MG (2011) Rescue of DeltaF508-CFTR trafficking via a GRASP-dependent unconventional secretion pathway. Cell 146:746–760CrossRefPubMedGoogle Scholar
  4. 4.
    Ameen N, Silvis M, Bradbury NA (2007) Endocytic trafficking of CFTR in health and disease. J Cyst Fibros 6:1–14CrossRefPubMedCentralPubMedGoogle Scholar
  5. 5.
    Amaral MD (2004) CFTR and chaperones: processing and degradation. J Mol Neurosci 23:41–48CrossRefPubMedGoogle Scholar
  6. 6.
    Chua CE, Lim YS, Lee MG, Tang BL (2012) Non-classical membrane trafficking processes galore. J Cell Physiol 227:3722–3730CrossRefPubMedGoogle Scholar
  7. 7.
    Gee HY, Tang BL, Kim KH, Lee MG (2010) Syntaxin 16 binds to cystic fibrosis transmembrane conductance regulator and regulates its membrane trafficking in epithelial cells. J Biol Chem 285:35519–35527CrossRefPubMedCentralPubMedGoogle Scholar
  8. 8.
    Gee HY, Kim YW, Jo MJ, Namkung W, Kim JY, Park HW, Kim KS, Kim H, Baba A, Yang J, Kim E, Kim KH, Lee MG (2009) Synaptic scaffolding molecule binds to and regulates vasoactive intestinal polypeptide type-1 receptor in epithelial cells. Gastroenterology 137:607–617, 617 e601-604CrossRefPubMedGoogle Scholar
  9. 9.
    Park J, Kwak JO, Riederer B, Seidler U, Cole SP, Lee HJ, Lee MG (2014) Na+/H+ exchanger regulatory factor 3 is critical for multidrug resistance protein 4-mediated drug efflux in the kidney. J Am Soc Nephrol 25:726–736CrossRefPubMedGoogle Scholar
  10. 10.
    Silvis MR, Bertrand CA, Ameen N, Golin-Bisello F, Butterworth MB, Frizzell RA, Bradbury NA (2009) Rab11b regulates the apical recycling of the cystic fibrosis transmembrane conductance regulator in polarized intestinal epithelial cells. Mol Biol Cell 20:2337–2350CrossRefPubMedCentralPubMedGoogle Scholar
  11. 11.
    Lukacs GL, Segal G, Kartner N, Grinstein S, Zhang F (1997) Constitutive internalization of cystic fibrosis transmembrane conductance regulator occurs via clathrin-dependent endocytosis and is regulated by protein phosphorylation. Biochem J 328(Pt 2):353–361PubMedCentralPubMedGoogle Scholar
  12. 12.
    Hong W (2005) SNAREs and traffic. Biochim Biophys Acta 1744:493–517CrossRefPubMedGoogle Scholar
  13. 13.
    Elia G (2012) Cell surface protein biotinylation for SDS-PAGE analysis. Methods Mol Biol 869:361–372CrossRefPubMedGoogle Scholar
  14. 14.
    Altan-Bonnet N, Sougrat R, Lippincott-Schwartz J (2004) Molecular basis for Golgi maintenance and biogenesis. Curr Opin Cell Biol 16:364–372CrossRefPubMedGoogle Scholar
  15. 15.
    Klausner RD, Donaldson JG, Lippincott-Schwartz J (1992) Brefeldin A: insights into the control of membrane traffic and organelle structure. J Cell Biol 116:1071–1080CrossRefPubMedGoogle Scholar
  16. 16.
    Yoo JS, Moyer BD, Bannykh S, Yoo HM, Riordan JR, Balch WE (2002) Non-conventional trafficking of the cystic fibrosis transmembrane conductance regulator through the early secretory pathway. J Biol Chem 277:11401–11409CrossRefPubMedGoogle Scholar
  17. 17.
    Nieland TJ, Feng Y, Brown JX, Chuang TD, Buckett PD, Wang J, Xie XS, McGraw TE, Kirchhausen T, Wessling-Resnick M (2004) Chemical genetic screening identifies sulfonamides that raise organellar pH and interfere with membrane traffic. Traffic 5:478–492CrossRefPubMedCentralPubMedGoogle Scholar
  18. 18.
    Peterson JR, Mitchison TJ (2002) Small molecules, big impact: a history of chemical inhibitors and the cytoskeleton. Chem Biol 9:1275–1285CrossRefPubMedGoogle Scholar
  19. 19.
    Brezillon S, Zahm JM, Pierrot D, Gaillard D, Hinnrasky J, Millart H, Klossek JM, Tummler B, Puchelle E (1997) ATP depletion induces a loss of respiratory epithelium functional integrity and down-regulates CFTR (cystic fibrosis transmembrane conductance regulator) expression. J Biol Chem 272:27830–27838CrossRefPubMedGoogle Scholar
  20. 20.
    Wang Q, Li L, Ye Y (2008) Inhibition of p97-dependent protein degradation by Eeyarestatin I. J Biol Chem 283:7445–7454CrossRefPubMedCentralPubMedGoogle Scholar
  21. 21.
    Fenteany G, Standaert R, Lane W, Choi S, Corey E, Schreiber S (1995) Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268:726–731CrossRefPubMedGoogle Scholar
  22. 22.
    Qin H, Shao Q, Igdoura SA, Alaoui-Jamali MA, Laird DW (2003) Lysosomal and proteasomal degradation play distinct roles in the life cycle of Cx43 in gap junctional intercellular communication-deficient and -competent breast tumor cells. J Biol Chem 278:30005–30014CrossRefPubMedGoogle Scholar
  23. 23.
    Miller SG, Carnell L, Moore HH (1992) Post-Golgi membrane traffic: brefeldin A inhibits export from distal Golgi compartments to the cell surface but not recycling. J Cell Biol 118:267–283CrossRefPubMedGoogle Scholar
  24. 24.
    Denning GM, Anderson MP, Amara JF, Marshall J, Smith AE, Welsh MJ (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358:761–764CrossRefPubMedGoogle Scholar
  25. 25.
    Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839–850CrossRefPubMedGoogle Scholar
  26. 26.
    Araki N, Johnson MT, Swanson JA (1996) A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages. J Cell Biol 135:1249–1260CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  1. 1.Department of Pharmacology, Brain Korea 21 PLUS Project for Medical Sciences, Severance Biomedical Science InstituteYonsei University College of MedicineSeoulKorea

Personalised recommendations